Table 6.

Statistical analysis of the prediction outcomes, A, S, FA in %. The first row for each patient corresponds to the metrics calculated on all experimental trials (all) while the second row shows the same calculated for testing trials (test) which were not used for training.

Patient#	Trial	N,NTD	TP,TN,FP,FN	A	S	FA	mcc, p-value
PD1	all	16,2	14,1,1,0	93.8	100	NC	0.68, 0.006
	test	9,1	7,1,1,0	88.9	100	NC	0.66,NC
PD2	all	26,4	16,3,7,0	73.1	100	NC	0.46, 0.02
	test	16,2	10,2,4,0	75.0	100	NC	0.49,0.05
PD3	all	17,0	15,0,2,0	88.2	100	NC	NA
	test	10,0	9,0,1,0	90.0	100	NC	NA
PD4	all	32,11	16,8,8,0	75.0	100	27.3	0.53, 0.003
	test	20,7	10,5,5,0	75.0	100	28.6	0.58, 0.01
All PD	all	91,17	61,12,18,0	80.2	100	29.4	0.56, 10−10
	test	55,10	36,8,11,0	80.0	100	20.0	0.57, 10−4
ET1	all	15,3	10,2,3,0	80.0	100	NC	0.55, 0.03
	test	9,2	5,2,2,0	77.8	100	NC	0.6, NC
ET2	all	30,14	13,14,3,0	90.0	100	0	0.82, 0.0001
	test	18,7	9,7,2,0	88.9	100	0	0.8, 0.0007
ET3	all	16,6	10,5,1,0	87.5	100	16.7	0.87, 0.0005
	test	10,5	5,4,1,0	90.0	100	20	0.82, NC
ET4	all	30,20	7,17,6,0	80.0	100	15	0.63, 0.0005
	test	18,12	4,11,3,0	83.3	100	8.3	0.67, 0.005
All ET	all	91,43	40,38,13,0	85.7	100	11.6	0.71, 0
	test	55,26	23,24,8,0	85.5	100	7.7	0.75, 10−8

Note: NC means not calculated; mcc could not be calculated for PD3 (NA) due to an indeterminate form (TN=FN=0); a p-value was calculated only when N > 10; FA for PD4 and for overall PD are not same because although FA was not calculated for PD(1-3), PD(1-2) had a few NTD trials which were included in the calculation of overall FA